
Hikma Pharmaceuticals USA Inc. is a recognized leader for the research, development, sales, and marketing of multisource pharmaceutical products. Specific to Addiction Treatment, Hikma Pharmaceuticals offers the following products; Methadone HCI Oral Concentrate, Methadone 40mg Diskets® Dispersible Tablets, Methadone 5mg and 10mg Tablets, Buprenorphine HCI Sublingual Tablets, Buprenorphine HCI and Naloxone Sublingual Tablets, and Buprenorphine and Naloxone Sublingual Film. In addition, Hikma is now excited to offer Kloxxado®, an 8mg Naloxone Nasal Spray.
For additional product information, including the Full Prescribing Information with complete indications for use, warnings, precautions and adverse reactions for each product, please visit AddictionTherapyServices.com.
PharmaceuticalTreatment - OutpatientTreatment Program